Pyxis Oncology, Inc. Common Stock (PYXS) is a publicly traded Healthcare sector company. As of September 1, 2026, PYXS trades at $3.25 with a market cap of $269.41M and a P/E ratio of -2.23. PYXS moved +0.00% today. Year to date, PYXS is +181.74%; over the trailing twelve months it is +153.13%. Its 52-week range spans $0.83 to $5.55. Analyst consensus is strong buy with an average price target of $7.14. Rallies surfaces PYXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PYXS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.25 |
| Market Cap | $269.41M |
| P/E Ratio | -2.23 |
| EPS | $-1.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.55 |
| 52-Week Low | $0.83 |
| Volume | 18.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $11.04M |
| Net Income | $-88.73M |
| Gross Margin | 0.00% |
8 analysts cover PYXS: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.14.